NED
Nancy E. Dempze Portfolio holdings
AUM
$173M
This Quarter Return
+10.32%
1 Year Return
+12.54%
3 Year Return
+67.49%
5 Year Return
+107.15%
10 Year Return
–
AUM
$89.3M
AUM Growth
+$89.3M
(+9.2%)
Cap. Flow
-$842K
Cap. Flow
% of AUM
-0.94%
Top 10 Holdings %
Top 10 Hldgs %
37.12%
Holding
79
New
3
Increased
19
Reduced
44
Closed
1
Top Buys
| 1 |
PayPal
PYPL
|
$326K |
| 2 |
NVIDIA
NVDA
|
$289K |
| 3 |
Cisco
CSCO
|
$204K |
| 4 |
Parker-Hannifin
PH
|
$202K |
| 5 |
Chubb
CB
|
$152K |
Top Sells
| 1 |
Procter & Gamble
PG
|
$267K |
| 2 |
Gilead Sciences
GILD
|
$228K |
| 3 |
Automatic Data Processing
ADP
|
$211K |
| 4 |
DuPont de Nemours
DD
|
$204K |
| 5 |
Mastercard
MA
|
$195K |
Sector Composition
| 1 | Healthcare | 24.99% |
| 2 | Technology | 21.41% |
| 3 | Industrials | 15.63% |
| 4 | Financials | 10.9% |
| 5 | Consumer Staples | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
EOG Resources
EOG
$68.8B
| $1.2M | 1.34% |
9,372
+244
| +3% | +$31.1K |
|
27
Fortive
FTV
$16B
| $1.06M | 1.18% |
12,542
-3
| -0% | -$252 |
|
|
CELG
28
DELISTED
Celgene Corp
CELG
| $1.03M | 1.15% |
11,504
+1,410
| +14% | +$126K |
|
29
Exxon Mobil
XOM
$489B
| $855K | 0.96% |
10,058
-100
| -1% | -$8.5K |
|
30
JPMorgan Chase
JPM
$824B
| $761K | 0.85% |
6,745
| – | – |
|
31
Visa
V
$679B
| $728K | 0.82% |
4,850
-20
| -0.4% | -$3K |
|
|
32
PayPal
PYPL
$66.2B
| $680K | 0.76% |
7,718
+3,703
| +92% | +$326K |
|
33
Merck
MRK
$214B
| $658K | 0.74% |
9,274
-10
| -0.1% | -$710 |
|
34
Walt Disney
DIS
$213B
| $615K | 0.69% |
5,258
+375
| +8% | +$43.9K |
|
35
TJX Companies
TJX
$155B
| $607K | 0.68% |
5,424
| – | – |
|
36
Berkshire Hathaway Class B
BRK.B
$1.08T
| $569K | 0.64% |
2,658
| – | – |
|
37
Union Pacific
UNP
$132B
| $515K | 0.58% |
3,162
-58
| -2% | -$9.45K |
|
38
Alphabet (Google) Class C
GOOG
$2.56T
| $507K | 0.57% |
425
-15
| -3% | -$17.9K |
|
39
SPDR S&P 500 ETF Trust
SPY
$653B
| $494K | 0.55% |
1,700
-300
| -15% | -$87.2K |
|
40
Church & Dwight Co
CHD
$22.7B
| $481K | 0.54% |
8,100
| – | – |
|
41
Illinois Tool Works
ITW
$76.4B
| $474K | 0.53% |
3,365
-50
| -1% | -$7.04K |
|
42
Colgate-Palmolive
CL
$68.2B
| $461K | 0.52% |
6,874
-6
| -0.1% | -$402 |
|
43
Mettler-Toledo International
MTD
$26.3B
| $426K | 0.48% |
700
| – | – |
|
44
AbbVie
ABBV
$374B
| $416K | 0.47% |
4,391
-9
| -0.2% | -$853 |
|
45
PepsiCo
PEP
$206B
| $415K | 0.46% |
3,710
-690
| -16% | -$77.2K |
|
|
46
Gilead Sciences
GILD
$140B
| $402K | 0.45% |
5,210
-2,956
| -36% | -$228K |
|
47
Biogen
BIIB
$20.5B
| $389K | 0.44% |
1,100
-100
| -8% | -$35.4K |
|
48
Oracle
ORCL
$633B
| $384K | 0.43% |
7,451
-3,745
| -33% | -$193K |
|
49
Emerson Electric
EMR
$73.9B
| $378K | 0.42% |
4,932
-28
| -0.6% | -$2.15K |
|
50
Becton Dickinson
BDX
$53.9B
| $339K | 0.38% |
1,300
-400
| -24% | -$104K |
|